HedgeChatter

  • Home /
  • Tag Archives

SVA

Sinovac to Host Conference Call to Report First Quarter 2014 Unaudited Financial Results

[PR Newswire] – BEIJING, May 12, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results … moreView todays social media effects on SVAView the latest stocks trending across Twitter. Click to view dashboardSee who Sinovac is hiring next, click here to view […]

May 12, 2014 Bystocknews , Comments Off on Sinovac to Host Conference Call to Report First Quarter 2014 Unaudited Financial Results read more

Sinovac Biotech (SVA) Soars: Stock Rises 17.1%

moreView todays social media effects on SVAView the latest stocks trending across Twitter. Click to view dashboardSee who Sinovac is hiring next, click here to view […]

March 21, 2014 Bystocknews , Comments Off on Sinovac Biotech (SVA) Soars: Stock Rises 17.1% read more

Sinovac to Host Conference Call to Report Fourth Quarter…

[at noodls] – Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2013 Unaudited Financial Results BEIJING, March 12, 2014 — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical … moreView todays social media effects on SVAView the latest stocks trending across Twitter. Click to view dashboardSee who Sinovac is hiring next, click here to […]

March 18, 2014 Bystocknews , Comments Off on Sinovac to Host Conference Call to Report Fourth Quarter… read more

5:02 pm Sinovac Biotech: EV71 vaccine Phase 3 clinical trial results published in NEJM; Study shows vaccine provides protection against EV71-associated hand, foot and mouth disease in infants and young children

moreView todays social media effects on SVAView the latest stocks trending across Twitter. Click to view dashboardSee who Sinovac is hiring next, click here to view […]

February 27, 2014 Bystocknews , Comments Off on 5:02 pm Sinovac Biotech: EV71 vaccine Phase 3 clinical trial results published in NEJM; Study shows vaccine provides protection against EV71-associated hand, foot and mouth disease in infants and young children read more

5:02 pm Sinovac Biotech: EV71 vaccine Phase 3 clinical trial results published in NEJM; Study shows vaccine provides protection against EV71-associated hand, foot and mouth disease in infants and young children

moreView todays social media effects on SVAView the latest stocks trending across Twitter. Click to view dashboardSee who Sinovac is hiring next, click here to view […]

February 26, 2014 Bystocknews , Comments Off on 5:02 pm Sinovac Biotech: EV71 vaccine Phase 3 clinical trial results published in NEJM; Study shows vaccine provides protection against EV71-associated hand, foot and mouth disease in infants and young children read more

Sinovac’s EV71 Vaccine Phase III Clinical Trial Results Published in New England Journal of Medicine

[PR Newswire] – BEIJING, Feb. 26, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that Phase III clinical trial results for its proprietary Enterovirus 71 (EV71) vaccine have bee moreView todays social media effects on SVAView the latest stocks trending across Twitter. Click to view dashboardSee who Sinovac is hiring next, […]

February 26, 2014 Bystocknews , Comments Off on Sinovac’s EV71 Vaccine Phase III Clinical Trial Results Published in New England Journal of Medicine read more

13th DCVMN Conference: DCVMN Must Become Stronger

[ACN Newswire] – Through Establishing Greater Cooperation throughout the Developing World on Vaccine Research and Development Bali, Indonesia, Nov 2, 2012 – (ACN Newswire) – The Developing Countries Vaccine Manufacturers … moreView todays social media effects on SVAView the latest stocks trending across Twitter. Click to view dashboard […]

November 2, 2012 Bystocknews , Comments Off on 13th DCVMN Conference: DCVMN Must Become Stronger read more

13th DCVMN Conference: Bill and Melinda Gates Foundation Applauds Bio Farma

[ACN Newswire] – Bali, Indonesia, Nov 1, 2012 – (ACN Newswire) – Bill and Melinda Gates Foundation appreciates Indonesia, especially Bio Farma for hosting an esteemed Developing Countries Vaccine Manufacturers Network … moreView todays social media effects on SVAView the latest stocks trending across Twitter. Click to view dashboard […]

November 1, 2012 Bystocknews , Comments Off on 13th DCVMN Conference: Bill and Melinda Gates Foundation Applauds Bio Farma read more

13th DCVMN Conference: Bio Farma Exports Products to 117 Countries

[ACN Newswire] – Bali, Indonesia, Oct 31, 2012 – (ACN Newswire) – Indonesian vaccine-making company Bio Farma has exported its product to 117 countries, making it one of the largest exporters of vaccine in the developing … moreView todays social media effects on SVAView the latest stocks trending across Twitter. Click to view dashboard […]

October 31, 2012 Bystocknews , Comments Off on 13th DCVMN Conference: Bio Farma Exports Products to 117 Countries read more

13th DCVMN Conference: Bio Farma’s Initiatives in Vaccine Cooperation Lauded

[ACN Newswire] – Bali, Indonesia, Oct 30, 2012 – (ACN Newswire) – The Developing Countries Vaccine Manufacturers Network (DCVMN) has lauded the initiatives and cooperation of Indonesian vaccine-maker Bio Farma, now the … moreView todays social media effects on SVAView the latest stocks trending across Twitter. Click to view dashboard […]

October 30, 2012 Bystocknews , Comments Off on 13th DCVMN Conference: Bio Farma’s Initiatives in Vaccine Cooperation Lauded read more